Ibnsina Pharma

ibnsinapharma originally established in 2001, today Ibnsina Pharma is Egypt’s fastest-growing and second largest pharmaceutical distribution company. The Company distributes a competitive portfolio of pharmaceutical products from over 350 Egyptian and multinational pharmaceutical companies to more than 42,000 customers including pharmacies, hospitals, retail outlets and wholesalers. Its fleet of around 650 vehicles completes an average of over 460,000 deliveries each month. Ibnsina Pharma’s core services for suppliers include management of warehousing and logistics for pharmaceutical products as well as the development and execution of tailored marketing solutions targeting a nationwide database of customers. The Company also provides efficient and reliable order-taking and delivery services to customers and was the first in its industry to pioneer a telesales model. Operating across 59 sites in 23 cities nationwide, Ibnsina Pharma’s team of more than 5,500 employees is dedicated to improving people’s quality of life by ensuring their access to safe and high quality pharmaceutical products.

Acebright Pharmaceuticals Group Co.,Ltd.

Shanghai Acebright Pharmaceuticals Group Co.,Ltd. (formerly Shanghai Desano Group) was founded in 1996. We are an innovative pharmaceutical enterprise with influential brand in the healthcare industry. Headquartered in Shanghai Zhangjiang Hi-Tech Park, Acebright has established a number of GMP standard manufacturing sites in China (Shanghai , Dafeng, Qidong, Chifeng) and India (Bangalore, Goa) to provide high quality products and related services to our customers worldwide. Among the subsidiaries of Acebright , five companies have been granted as provincial High Enterprises, seven companies have obtained GMP certificates of CFDA, three manufacturing facilities are approved by US FDA. Acebright continuously invests in technology innovation and development. We have set up a corporate R&D Center, a state-level Enterprise Technology Center, the National Key Laboratory of Antibody Drugs Research and Post doctoral Research Station to build solid foundation for the company’s growth. We have set up two business platforms (B-to-B platform and B-to-C platform) to meet the demands of all our clients around the world. Through the B-to-B platform, we focus on the business of pharmaceutical intermediates, APIs, nutritional ingredients, and CRO and CMO services. Acebright has set up an integrated and highly efficient operation system from R&D, manufacturing to sales & marketing to provide high quality products and professional services to our customers and partners in the pharmaceutical and nutraceutical business. The B-to-C platform is dedicated to providing finished drug products of Oncology, anti-HIV/AIDS, Penem, Monoclonal antibody drugs and other biological products to our worldwide customers (doctors and patients). At Acebright, “We care for life,We work for human health”. Driven by technology innovation and global vision, Acebright strives to be a reliable partner for your pharmaceutical business.

Wockhardt Ltd.

Wockhardt is a global pharmaceutical and biotechnology organization, providing affordable, high-quality medicines for a healthier world. It is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Specialty Hospitals. Wockhardt is a true Indian Multi-National Company with a multi-ethnic workforce of 3000 Wockhardt Associates from 21 different nationalities globally. It has 3 research centers and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines. Headquartered in Mumbai, India, Wockhardt has full-fledged operations in the USA, UK, Ireland and France. It also has its marketing presence in emerging markets of Russia, Brazil, Mexico, Vietnam, Philippines, Nigeria, Kenya, Ghana, Tanzania, Uganda, Nepal, Myanmar, Sri Lanka, Mauritius, Lebanon and Kuwait. Wockhardt’s core business is innovation. It uses science and technology to develop medicines and other products that improve the quality of millions people’s lives through better health. Wockhardt aspires to create a healthier world. Its strategic vision of ‘More & More with Less & Less’ has transformed into new ways of thinking, a new journey for growth, medical breakthroughs for patients and continuing value for all stakeholders.

EVERSANA

EVERSANA® is a leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com.

unimed unihealth group

UniMed UniHealth began its journey in the year 1997 in Bangladesh by introducing life-saving and innovative pharmaceutical products from world class pharmaceutical companies like Grunenthal, Biotest, Abbott, Janssen and Vifor. A team of dedicated professionals having experience in multinational and leading local pharmaceutical companies under the leadership of Mr M Mosaddek Hossain prepared the plan, determined the strategies and progressed to develop the organization. Within a short period of time, the organization could successfully introduce a number of new chemical entities (NCEs) providing improved benefits to the patients. The development of manufacturing capabilities in the year 2000 allowed introduction of a large number of branded generics in a number of specialty therapeutic areas. UniMed UniHealth ensured highest quality products from the beginning through procurement of active ingredients and excipients from selected and controlled sources, systematically processing in well designed and equipped facilities in compliance to regulatory requirements maintaining cGMP, GLP and ISO standards. UniMed UniHealth organized professional marketing with focused promotion through dedicated well trained teams and supplied the products throughout the country with its own developed distribution network. UniMed UniHealth believes and adheres to values like Quality, Knowledge and Responsibility in all aspects of its operation and earned respect and recognition of its valued customers in the healthcare sector of Bangladesh.